inci yildirim

inci yildirim

Yale University

H-index: 37

North America-United States

About inci yildirim

inci yildirim, With an exceptional h-index of 37 and a recent h-index of 28 (since 2020), a distinguished researcher at Yale University, specializes in the field of Vaccines, vaccine induced immune response in immunocompromised populations.

His recent articles reflect a diverse array of research interests and contributions to the field:

Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older Adults

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A (H7N9) Inactivated …

A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults

The impact of antigenic distance on Orthopoxvirus Vaccination and Mpox Infection for cross-protective immunity

Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A (H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial

Development and comparison of immunologic assays to detect primary RSV infections in infants

Global Impact of 10-and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in All Ages: The PSERENADE Project

Invasive Pneumococcal Disease After 2 Decades of Pneumococcal Conjugate Vaccine Use

inci yildirim Information

University

Position

___

Citations(all)

12168

Citations(since 2020)

10722

Cited By

3512

hIndex(all)

37

hIndex(since 2020)

28

i10Index(all)

82

i10Index(since 2020)

59

Email

University Profile Page

Google Scholar

inci yildirim Skills & Research Interests

Vaccines

vaccine induced immune response in immunocompromised populations

Top articles of inci yildirim

Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older Adults

Clinical Infectious Diseases

2024/4/15

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A (H7N9) Inactivated …

Clinical Infectious Diseases

2024/3/27

A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults

The Journal of Infectious Diseases

2024/3/27

The impact of antigenic distance on Orthopoxvirus Vaccination and Mpox Infection for cross-protective immunity

medRxiv

2024

Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A (H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial

The Journal of infectious diseases

2024/2/15

Inci Yildirim
Inci Yildirim

H-Index: 19

Julia Weiss
Julia Weiss

H-Index: 1

Development and comparison of immunologic assays to detect primary RSV infections in infants

Frontiers in Immunology

2024/1/12

Inci Yildirim
Inci Yildirim

H-Index: 19

Global Impact of 10-and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in All Ages: The PSERENADE Project

2024

Invasive Pneumococcal Disease After 2 Decades of Pneumococcal Conjugate Vaccine Use

Pediatrics

2024/1/1

Inci Yildirim
Inci Yildirim

H-Index: 19

Hanna Lee
Hanna Lee

H-Index: 4

Environmental surveillance for COVID-19 using SARS-CoV-2 RNA concentration in wastewater–a study in District East, Karachi, Pakistan

The Lancet Regional Health-Southeast Asia

2024/1/1

Inci Yildirim
Inci Yildirim

H-Index: 19

Windy Tanner
Windy Tanner

H-Index: 7

Adjunctive diagnostic studies completed following detection of candidemia in children: secondary analysis of observed practice from a multicenter cohort study conducted by the …

Journal of the Pediatric Infectious Diseases Society

2023/9/1

Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population

Nature communications

2023/8/19

Inci Yildirim
Inci Yildirim

H-Index: 19

Plain Language Summary of a Clinical Trial Evaluating mRNA-1273, Moderna's mRNA-Based COVID-19 Vaccine, in Children 6 Through 11 Years of Age

2023/7

Incidence of cytomegalovirus DNAemia in pediatric kidney, liver, and heart transplant recipients: Efficacy and risk factors associated with failure of weight‐based dosed …

Pediatric Transplantation

2023/6

Inci Yildirim
Inci Yildirim

H-Index: 19

Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine–associated myocarditis

Science Immunology

2023/5/5

Assessing the effectiveness of COVID-19 vaccines in Pakistan: a test-negative case-control study

Journal of Infection

2023/5/1

Inci Yildirim
Inci Yildirim

H-Index: 19

Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants

New England Journal of Medicine

2023/4/20

Nonsystematic Reporting Biases of the SARS-CoV-2 Variant Mu Could Impact Our Understanding of the Epidemiological Dynamics of Emerging Variants

Genome Biology and Evolution

2023/4/1

SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity

Nature communications

2023/3/9

COVID-19 Vaccine Acceptance and Hesitancy among Health Care Workers in Lebanon

Journal of Epidemiology and Global Health

2023/3

Inci Yildirim
Inci Yildirim

H-Index: 19

Kaveh Khoshnood
Kaveh Khoshnood

H-Index: 19

See List of Professors in inci yildirim University(Yale University)

Co-Authors

academic-engine